Dr. Berry, a practicing biochemical geneticist and pediatric endocrinologist as well as a renowned scientist, is the Harvey Levy Chair in Metabolism and Director of the Metabolism Program at the Boston Children’s Hospital, and Professor of Pediatrics at the Harvard Medical School, and Director of the Harvard Medical School Biochemical Genetics Training Program. He is a Member of the Board of Directors of the Society of Inherited Metabolic Disorders, and a Communicating Editor for the Journal of Inherited Metabolic Diseases. His review panel and other NIH service work included serving as a Member of Gene Therapy and Inborn Errors (GTIE) Special Emphasis Panel, a Member of the Therapeutic Advances for Genetic Diseases (TAG) study section and the Chairman of the Rare Diseases Clinical Research Network Data and Safety Monitoring Board 2. Dr. Berry has been the recipient of many NIH and non-federal grant awards. He has published over 150 peer reviewed papers and over 40 book chapters. Dr. Berry was the recipient of the 2004 Emmanuel Shapiro Award from the Sociery for Inherited Metabolic Disorders. He is the site principal investigator for a NIH-funded multicenter trial to determine to evaluate treatments of urea cycle disorders and organic acidemias. Dr. Berry’s primary basic science and clinical research efforts have focused on Galactosemia, myo-inositol metabolism in the brain, and other metabolic disorders.
Gerard T. Berry, M.D.